|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,327.60 INR | -1.78% |
|
+4.32% | -1.34% |
Upcoming dividends: Concord Biotech Limited
| 24/07/2026 | Ex-dividend date | 7.55 Concord Biotech Limited, 7.55 (INR), Cash Dividend, Jul-24-2026 | 09:30 am |
EPS & Dividend: Concord Biotech Limited
| Fiscal Period: March | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| Dividend per Share 2 | 8.75 | 10.7 | 7.55 | 9.733 | 13.8 | 13.2 |
| Rate of return | 0.58% | 0.64% | 0.74% | 0.72% | 1.02% | 0.98% |
| EPS 2 | 29.45 | 35.52 | 24.78 | 33.48 | 42.46 | 51.39 |
| Distribution rate | 29.7% | 30.1% | 30.5% | 29.1% | 32.5% | 25.7% |
| Reference price 2 | 1,520.80 | 1,680.60 | 1,018.40 | 1,351.70 | 1,351.70 | 1,351.70 |
| Nbr of stocks (in thousands) | 1,04,616 | 1,04,616 | 1,04,616 | 1,04,616 | - | - |
| Announcement Date | 24/05/24 | 29/05/25 | 29/05/26 | - | - | - |
Past dividends: Concord Biotech Limited
| 03/09/2025 | Ex-dividend date - 10.7 INR | 09:30 am |
Upcoming Events: Concord Biotech Limited
| 31/07/2026 | Annual General Meeting | 12:00 pm | |
| 31/07/2026 | Présentation aux Actionnaires / Analystes | 12:00 pm |
| Dividend Yield (Y) | Dividend Yield (Y+1) | P/E (Y) | Price to Book (Y) | EV / Sales (Y) | ||
|---|---|---|---|---|---|---|
 | 0.85% | 0.72% | 49.25x | 6.94x | 11.94x | |
| 0.59% | 0.67% | 17.43x | 1.98x | 3.76x | |
| 0.62% | 0.64% | 25.46x | 3.82x | 5.22x | |
| -.--% | -.--% | 34.63x | 6.96x | 11.76x | |
| 3.39% | 3.47% | -45.31x | 2.47x | 3.19x | |
| -.--% | -.--% | 34.82x | 1.65x | 3.61x | |
| -.--% | -.--% | -7.73x | 4.69x | 11.07x | |
| -.--% | -.--% | 33.48x | 3.32x | 3.12x | |
| -.--% | 0.05% | 61.71x | 5.7x | 6.26x | |
| -.--% | -.--% | 25.61x | 3.6x | 5.29x | |
| Average | 0.54% | 0.56% | 22.93x | 4.11x | 6.52x | |
| Weighted average by Cap. | 0.65% | 0.69% | 17.18x | 3.64x | 5.82x |
Year-on-year evolution of the Yield
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Estimates Revisions
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
Annual Profit -
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition